PHARMACEUTICAL PRODUCT DEVELOPMENT INC Direct Operating Costs
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Direct Operating Costs of $192.17 million for the 3-month period ending 2010-06-30, per its 10-Q filed 2010-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCosts · last filed 2010-08-06
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC direct operating costs for the quarter ending 2010-06-30 was $192.17M, a 5.08% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC direct operating costs for the quarter ending 2009-06-30 was $182.89M.
| Period end | Direct Operating Costs 3 month | Direct Operating Costs 6 month |
|---|---|---|
| 2010-06-30 | $192.17M 10-Q · filed 2010-08-06 | $374.97M 10-Q · filed 2010-08-06 |
| 2009-06-30 | $182.89M 10-Q · filed 2010-08-06 | $371.21M 10-Q · filed 2010-08-06 |